MTOR and nonpapillary renal cell carcinoma: In the present study, the mRNA expression levels of the aforementioned nine genes demonstrated no significant differences between ccRCC and normal tissues (P > 0.05), suggesting that the activation of the PI3K/AKT/mTOR signaling pathway in patients with ccRCC may not be dependent on their transcriptional regulation.